Akèy › Kansè bouch
Etid klinik pou Kansè bouch ap rekrite nan Etazini
44 etid pou Kansè bouch ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Atlanta, GA9 etid
- New York City, NY8 etid
- Chicago, IL8 etid
- St. Louis, MO8 etid
- Durham, NC7 etid
- Pittsburgh, PA7 etid
- Milwaukee, WI7 etid
- Kansas City, MO7 etid
- Ann Arbor, MI7 etid
- Houston, TX7 etid
- Richmond, VA7 etid
- Edison, NJ6 etid
- Philadelphia, PA6 etid
- Nashville, TN6 etid
- Kansas City, KS6 etid
- Omaha, NE6 etid
- Oklahoma City, OK6 etid
- Portland, OR6 etid
- Queens, NY5 etid
- Decatur, IL5 etid
- Mountain View, CA5 etid
- Naperville, IL5 etid
- Erie, PA5 etid
- Detroit, MI5 etid
- Champaign, IL5 etid
- Charleston, IL5 etid
- Los Angeles, CA5 etid
- Danville, IL5 etid
- Overland Park, KS5 etid
- Phoenix, AZ5 etid
- Stevens Point, WI5 etid
- Joliet, IL5 etid
- Peoria, IL5 etid
- Bloomington, IL5 etid
- Wausau, WI5 etid
- Cedar Rapids, IA5 etid
- Cape Girardeau, MO5 etid
- Baltimore, MD5 etid
- Cincinnati, OH5 etid
- Toledo, OH4 etid
Pa eta
- Arizona7 etid
- Arkansas5 etid
- Colorado8 etid
- Connecticut3 etid
- Florid11 etid
- Georgia9 etid
- Idaho3 etid
- Illinois10 etid
- Indiana5 etid
- Iowa8 etid
- Kalifòni13 etid
- Kansas9 etid
- Kentucky5 etid
- Lwizyàn3 etid
- Maryland6 etid
- Massachusetts5 etid
- Michigan9 etid
- Minnesota8 etid
- Missouri10 etid
- Montana4 etid
- Nebraska6 etid
- New Hampshire4 etid
- New Jersey8 etid
- New Mexico3 etid
- New York13 etid
- North Carolina9 etid
- North Dakota4 etid
- Ohio14 etid
- Oklahoma6 etid
- Oregon6 etid
- Pennsylvania10 etid
- South Carolina5 etid
- South Dakota4 etid
- Tennessee8 etid
- Texas9 etid
- Vermont3 etid
- Virginia7 etid
- Wisconsin9 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07195734DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT05172245Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06736379Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07343596Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07156227Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07441681Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07110142Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT06627270Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT06819228Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07121595Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT06448026Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT01269190Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766Role of Acetaldehyde in the Development of Oral Cancer
Ap rekriteVolontè an sante akeyi
Laj 18 a 45 · Tout sèks · Mizajou Jul 22, 2026 · NCT05973656Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT06662058Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07460765Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.